Literature DB >> 18305084

Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy.

Claudia Ypenburg1, Patrizio Lancellotti, Laurens F Tops, Eric Boersma, Gabe B Bleeker, Eduard R Holman, James D Thomas, Martin J Schalij, Luc A Piérard, Jeroen J Bax.   

Abstract

AIMS: The aim of the current study was to evaluate the relationship between the presence of left ventricular (LV) dyssynchrony at baseline and acute vs. late improvement in mitral regurgitation (MR) after cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: Sixty eight patients consecutive (LV ejection fraction 23 +/- 8%) with at least moderate MR (>or=grade 2+) were included. Echocardiography was performed at baseline, 1 day after CRT initiation and at 6 months follow-up. Speckle tracking radial strain was used to assess LV dyssynchrony at baseline. The majority of patients improved in MR after CRT, with 43% improving immediately after CRT, and 20% improving late (after 6 months) after CRT. Early and late responders had similar extent of LV dyssynchrony (209 +/- 115 ms vs. 190 +/- 118 ms, P = NS); however, the site of latest activation in early responders was mostly inferior or posterior (adjacent to the posterior papillary muscle), whereas the lateral wall was the latest activated segment in late responders.
CONCLUSION: Current data suggest that the presence of baseline LV dyssynchrony is related to improvement in MR after CRT. LV dyssynchrony involving the posterior papillary muscle may lead to an immediate reduction in MR, whereas LV dyssynchrony in the lateral wall resulted in late response to CRT.

Entities:  

Mesh:

Year:  2008        PMID: 18305084     DOI: 10.1093/eurheartj/ehn063

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  Cardiac dyssynchrony: we have the tools. It is time to use them.

Authors:  Steven Port
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

2.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients.

Authors:  Ulas Höke; Mand J H Khidir; Enno T van der Velde; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

Review 3.  Therapeutic decision-making for patients with fluctuating mitral regurgitation.

Authors:  Patrizio Lancellotti; Khalil Fattouch; Giovanni La Canna
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

Review 4.  Cardiac resynchronization therapy: history, present status, and future directions.

Authors:  Leeor M Jaffe; Daniel P Morin
Journal:  Ochsner J       Date:  2014

5.  Implantation of CARILLON® Mitral Contour System with transvenous left ventricular lead in place.

Authors:  T Wengenmayer; J Reinöhl; J Steinfurt; A Mittag; C Bode; J Biermann
Journal:  Clin Res Cardiol       Date:  2017-05-05       Impact factor: 5.460

6.  Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.

Authors:  Philippe B Bertrand; Ehud Schwammenthal; Robert A Levine; Pieter M Vandervoort
Journal:  Circulation       Date:  2017-01-17       Impact factor: 29.690

Review 7.  Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies.

Authors:  Zainab Samad; Eric J Velazquez
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

8.  Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy-The BIOCRT Study.

Authors:  Jonathan Beaudoin; Jagmeet P Singh; Jackie Szymonifka; Qing Zhou; Robert A Levine; James L Januzzi; Quynh A Truong
Journal:  Can J Cardiol       Date:  2016-06-02       Impact factor: 5.223

Review 9.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

10.  Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: optimization of the force-balance relationship.

Authors:  Jorge Solis; David McCarty; Robert A Levine; Mark D Handschumacher; Leticia Fernandez-Friera; Annabel Chen-Tournoux; Luis Mont; Barbara Vidal; Jagmeet P Singh; Josep Brugada; Michael H Picard; Marta Sitges; Judy Hung
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-22       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.